Navigation Links
Pharmaceutical Investment & Cost Benchmarks Accessed Quickly Through Best Practices, LLC's New Database Search Function
Date:11/16/2011

CHAPEL HILL, N.C., Nov. 16, 2011 /PRNewswire/ -- Savvy executives in pharmaceutical commercial functions examine investment and cost benchmarks to remain competitive in today's volatile healthcare environment. Quantitative and qualitative investment benchmarking data can support a business case for increased resources, justify costs, or signal necessary course changes.

To support pharmaceutical vice presidents, directors, and managers tasked with right-sizing investment levels and justifying costs, Best Practices, LLC launches Investment & Cost Benchmark Analyzer within the Wizards & Analytics Search (http://www3.best-in-class.com/rw16.htm). The new Wizard searches the Best Practice Database for investment and cost benchmarks on a specified function, group, or business issue, such as pharmaceutical new product launch.

How to Effectively Use the Investment & Cost Benchmark Analyzer:

  • Visit the Investment & Cost Benchmark Analyzer at http://www3.best-in-class.com/rw16.htm.  
  • In the second text box, insert the pharmaceutical business issue of "product launch" in quotations.
  • Click the "Search Now" button to the right of the text box.
  • Review the list of relevant documents in the Best Practice Database.
  • Click on the document titles of most interest, including the first hit "Winning in the U.S. Marketplace: Pre-launch and Launch Investment Benchmarks for New Products." (http://www3.best-in-class.com/rw18.htm)

Best Practice Database documents include benchmarks and insights gathered from quantitative and qualitative primary research with executives at pharmaceutical companies. Subscribers to the Best Practice Database have access to these primary research results to make informed decisions in their functional areas. Within the documents, charts, graphs, and process maps enable executives to assess resource levels, responsibility scope, and performance metrics of their function.

For more information on the Investment & Cost Benchmark Analyzer or how to determine if your group is among the low performers or the best-in-class performers, contact us at 919.403.0251 or at bestpractices@best-in-class.com.    

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide.

Best Practices, LLC's clients include the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our reports, database, and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Radient Pharmaceuticals Asks DHS Holding Co. to Retract News Release Saying It Will Enter Into Talks With Radient Pharmaceuticals Corporation
3. The Outlook for Pharmaceuticals in South East Asia
4. The Outlook for Pharmaceuticals in Western Europe
5. The Outlook for Pharmaceuticals in Central & Eastern Europe
6. The Outlook for Pharmaceuticals in the Middle East and North Africa
7. The Outlook for Pharmaceuticals in Brazil, Russia, India & China
8. The Outlook for Pharmaceuticals in Latin America
9. Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
10. Sustainability in the Global Pharmaceutical Industry 2011-2012: Market Trends and Opportunities, Profitability and Budget Forecasts, Pharmaceutical Industry Procurement and Marketing Initiatives
11. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Following an initial analysis, the Senior Care ... Drug Administration,s (FDA,s) final regulatory guidance regarding the ... and Outsourcing Facilities." In its final guidance, the ... which would have put patients at risk and ... (LTC) pharmacies.  The agency also ...
(Date:1/17/2017)... 2017   Anesthesia Business Consultants (ABC), ... for the anesthesia and pain management specialty, discusses ... "clinical conundrum" (as described recently in Anesthesiology News) ... think carefully before recommending medical marijuana for their ... National Academies of Sciences, Engineering and Medicine, " ...
(Date:1/17/2017)... -- Interpace Diagnostics Group, Inc., (NASDAQ: IDXG ), ... and pathology services for evaluating risks of cancer, announced ... 13, 2017 from the NASDAQ Listing Qualifications notifying the ... of the NASDAQ Stock Market to maintain a minimum ... The letter noted that for the last 10 days ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
(Date:1/17/2017)... ... 17, 2017 , ... Kevin Harrington (one of the original Sharks from mega-hit ... regarding the topic of Beauty and Personal Care. , Everyone makes ... way to commit to these changes than beginning with personal care and beauty products? ...
(Date:1/17/2017)... Houston, TX (PRWEB) , ... January 17, 2017 , ... ... they have earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. ... been named part of this elite group of providers. , Produced by Zeltiq, ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... A prescription ... winners of the fourth Cradle to Cradle Product Design Challenge , the ... in a series of six circular design challenges scheduled to run through early 2018. ...
(Date:1/17/2017)... ... ... SC&H Group, a leading audit, tax, and consulting firm, announced that Chris ... practice . Rossi is the third technology consulting leader to join SC&H Group’s IT ... the practice continues to expand.     , Bringing more than 25 years of business consulting ...
Breaking Medicine News(10 mins):